TJ

Thomas Jerussi

SE Sepracor: 40 patents #2 of 121Top 2%
SP Sunovion Pharmaceuticals: 10 patents #19 of 118Top 20%
TL The Boc Group Limited: 1 patents #283 of 612Top 50%
Pfizer: 1 patents #3,022 of 5,153Top 60%
Overall (All Time): #47,637 of 4,157,543Top 2%
54
Patents All Time

Issued Patents All Time

Showing 25 most recent of 54 patents

Patent #TitleCo-InventorsDate
10702486 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Qun Kevin Fang, Mark G. Currie 2020-07-07
10328036 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Qun Kevin Fang, Mark G. Currie 2019-06-25
9907764 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Qun Kevin Fang, Mark G. Currie 2018-03-06
9498452 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Qun Kevin Fang, Mark G. Currie 2016-11-22
9072699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2015-07-07
9072700 Methods of using derivatives of (−)-venlafaxine Chrisantha H. Senanayake, Nandkumar N. Bhongle 2015-07-07
8658700 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2014-02-25
8642662 Methods of using derivatives of (−)-venlafaxine Chrisantha H. Senanayake, Nandkumar N. Bhongle 2014-02-04
8344030 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2013-01-01
8269040 Derivatives of venlafaxine and methods of preparing and using the same Chrisantha H. Senanayake, Nandkumar N. Bhongle 2012-09-18
8134029 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2012-03-13
7790772 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2010-09-07
7723324 Imidazo[1,2-A]pyridine anxiolytics Q. Kevin Fang, Paul Grover 2010-05-25
7589237 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2009-09-15
7566725 Imidazo[1,2-A] pyridine anxiolytics Q. Kevin Fang, Paul Grover 2009-07-28
7456173 Compositions comprising zopiclone derivatives and methods of making and using the same Qun Kevin Fang 2008-11-25
7423179 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Qun Kevin Fang, Mark G. Currie 2008-09-09
7189715 Compositions comprising zopiclone derivatives and methods of making and using the same Qun Kevin Fang 2007-03-13
7148353 Imidazo[1,2-a] pyridine anxiolytics Kevin Fang, Paul Grover 2006-12-12
7105699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Qun Kevin Fang, Mark G. Currie 2006-09-12
7087785 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Qun Kevin Fang, Mark G. Currie 2006-08-08
7071234 Methods of treating or preventing erectile dysfunction Chrisantha H. Senanayake, Qun Kevin Fang 2006-07-04
6974837 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors Chrisantha H. Senanayake, Qun Kevin Fang 2005-12-13
6946464 Methods of treating and preventing a convulsive state Chrisantha H. Senanayake, Paul Rubin, Yaping Hong, Roger Bakale, Tingjian Xiang +1 more 2005-09-20
6911479 Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (−)-venlafaxine Chrisantha H. Senanayake, Nandkumar N. Bhongle 2005-06-28